Global and United States Bipolar Disorder Market Report & Forecast 2023-2028

Report ID: 1835463 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Bipolar Disorder Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Bipolar Disorder Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Bipolar Disorder Market Size for the Year 2017-2028
        1.2.2 Global Bipolar Disorder Market Size for the Year 2017-2028
    1.3 Bipolar Disorder Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Bipolar Disorder in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Bipolar Disorder Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Bipolar Disorder Market Dynamics
        1.4.1 Bipolar Disorder Industry Trends
        1.4.2 Bipolar Disorder Market Drivers
        1.4.3 Bipolar Disorder Market Challenges
        1.4.4 Bipolar Disorder Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Bipolar Disorder by Type
    2.1 Bipolar Disorder Market Segment by Type
        2.1.1 Bipolar I Disorder
        2.1.2 Bipolar II Disorder
        2.1.3 Cyclothymic Disorder
    2.2 Global Bipolar Disorder Market Size by Type (2017, 2022 & 2028)
    2.3 Global Bipolar Disorder Market Size by Type (2017-2028)
    2.4 United States Bipolar Disorder Market Size by Type (2017, 2022 & 2028)
    2.5 United States Bipolar Disorder Market Size by Type (2017-2028)
3 Bipolar Disorder by Application
    3.1 Bipolar Disorder Market Segment by Application
        3.1.1 Mood Stabilizers
        3.1.2 Anticonvulsants
        3.1.3 Antipsychotic drugs
        3.1.4 Antidepressant drugs
        3.1.5 Antianxiety drugs
        3.1.6 Others
    3.2 Global Bipolar Disorder Market Size by Application (2017, 2022 & 2028)
    3.3 Global Bipolar Disorder Market Size by Application (2017-2028)
    3.4 United States Bipolar Disorder Market Size by Application (2017, 2022 & 2028)
    3.5 United States Bipolar Disorder Market Size by Application (2017-2028)
4 Global Bipolar Disorder Competitor Landscape by Company
    4.1 Global Bipolar Disorder Market Size by Company
        4.1.1 Top Global Bipolar Disorder Companies Ranked by Revenue (2021)
        4.1.2 Global Bipolar Disorder Revenue by Player (2017-2022)
    4.2 Global Bipolar Disorder Concentration Ratio (CR)
        4.2.1 Bipolar Disorder Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Bipolar Disorder in 2021
        4.2.3 Global Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Bipolar Disorder Headquarters, Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Bipolar Disorder Headquarters and Area Served
        4.3.2 Global Bipolar Disorder Companies Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Bipolar Disorder Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Bipolar Disorder Market Size by Company
        4.5.1 Top Bipolar Disorder Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Bipolar Disorder Revenue by Players (2020, 2021 & 2022)
5 Global Bipolar Disorder Market Size by Region
    5.1 Global Bipolar Disorder Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Bipolar Disorder Market Size by Region (2017-2028)
        5.2.1 Global Bipolar Disorder Market Size by Region: 2017-2022
        5.2.2 Global Bipolar Disorder Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Bipolar Disorder Market Size YoY Growth 2017-2028
        6.1.2 North America Bipolar Disorder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Bipolar Disorder Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Bipolar Disorder Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Indonesia
        6.2.9 Thailand
        6.2.10 Malaysia
        6.2.11 Philippines
        6.2.12 Vietnam
    6.3 Europe
        6.3.1 Europe Bipolar Disorder Market Size YoY Growth 2017-2028
        6.3.2 Europe Bipolar Disorder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 UK
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Bipolar Disorder Market Size YoY Growth 2017-2028
        6.4.2 Latin America Bipolar Disorder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Brazil
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Bipolar Disorder Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Bipolar Disorder Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Glaxo SmithKline (GSK)
        7.1.1 Glaxo SmithKline (GSK) Company Details
        7.1.2 Glaxo SmithKline (GSK) Business Overview
        7.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Introduction
        7.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2017-2022)
        7.1.5 Glaxo SmithKline (GSK) Recent Development
    7.2 Pfizer Inc.
        7.2.1 Pfizer Inc. Company Details
        7.2.2 Pfizer Inc. Business Overview
        7.2.3 Pfizer Inc. Bipolar Disorder Introduction
        7.2.4 Pfizer Inc. Revenue in Bipolar Disorder Business (2017-2022)
        7.2.5 Pfizer Inc. Recent Development
    7.3 Janssen Pharmaceuticals
        7.3.1 Janssen Pharmaceuticals Company Details
        7.3.2 Janssen Pharmaceuticals Business Overview
        7.3.3 Janssen Pharmaceuticals Bipolar Disorder Introduction
        7.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2017-2022)
        7.3.5 Janssen Pharmaceuticals Recent Development
    7.4 Eli Lilly
        7.4.1 Eli Lilly Company Details
        7.4.2 Eli Lilly Business Overview
        7.4.3 Eli Lilly Bipolar Disorder Introduction
        7.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2017-2022)
        7.4.5 Eli Lilly Recent Development
    7.5 Allergan Plc.
        7.5.1 Allergan Plc. Company Details
        7.5.2 Allergan Plc. Business Overview
        7.5.3 Allergan Plc. Bipolar Disorder Introduction
        7.5.4 Allergan Plc. Revenue in Bipolar Disorder Business (2017-2022)
        7.5.5 Allergan Plc. Recent Development
    7.6 Novartis AG
        7.6.1 Novartis AG Company Details
        7.6.2 Novartis AG Business Overview
        7.6.3 Novartis AG Bipolar Disorder Introduction
        7.6.4 Novartis AG Revenue in Bipolar Disorder Business (2017-2022)
        7.6.5 Novartis AG Recent Development
    7.7 AbbVie Inc.
        7.7.1 AbbVie Inc. Company Details
        7.7.2 AbbVie Inc. Business Overview
        7.7.3 AbbVie Inc. Bipolar Disorder Introduction
        7.7.4 AbbVie Inc. Revenue in Bipolar Disorder Business (2017-2022)
        7.7.5 AbbVie Inc. Recent Development
    7.8 Otsuka Holdings Ltd
        7.8.1 Otsuka Holdings Ltd Company Details
        7.8.2 Otsuka Holdings Ltd Business Overview
        7.8.3 Otsuka Holdings Ltd Bipolar Disorder Introduction
        7.8.4 Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2017-2022)
        7.8.5 Otsuka Holdings Ltd Recent Development
    7.9 AstraZeneca
        7.9.1 AstraZeneca Company Details
        7.9.2 AstraZeneca Business Overview
        7.9.3 AstraZeneca Bipolar Disorder Introduction
        7.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2017-2022)
        7.9.5 AstraZeneca Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Bipolar Disorder Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Bipolar Disorder Market Trends
    Table 3. Bipolar Disorder Market Drivers
    Table 4. Bipolar Disorder Market Challenges
    Table 5. Bipolar Disorder Market Restraints
    Table 6. Global Bipolar Disorder Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Bipolar Disorder Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Bipolar Disorder Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Bipolar Disorder Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Bipolar Disorder Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Bipolar Disorder Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Bipolar Disorder Revenue Share by Player, 2017-2022
    Table 13. Global Bipolar Disorder Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Bipolar Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2021)
    Table 15. Top Players of Bipolar Disorder in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Bipolar Disorder Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Bipolar Disorder Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Bipolar Disorder Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Bipolar Disorder Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Bipolar Disorder Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Bipolar Disorder Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Bipolar Disorder Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Bipolar Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Bipolar Disorder Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Bipolar Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Bipolar Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Bipolar Disorder Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Glaxo SmithKline (GSK) Company Details
    Table 31. Glaxo SmithKline (GSK) Business Overview
    Table 32. Glaxo SmithKline (GSK) Bipolar Disorder Product
    Table 33. Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 34. Glaxo SmithKline (GSK) Recent Development
    Table 35. Pfizer Inc. Company Details
    Table 36. Pfizer Inc. Business Overview
    Table 37. Pfizer Inc. Bipolar Disorder Product
    Table 38. Pfizer Inc. Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Inc. Recent Development
    Table 40. Janssen Pharmaceuticals Company Details
    Table 41. Janssen Pharmaceuticals Business Overview
    Table 42. Janssen Pharmaceuticals Bipolar Disorder Product
    Table 43. Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 44. Janssen Pharmaceuticals Recent Development
    Table 45. Eli Lilly Company Details
    Table 46. Eli Lilly Business Overview
    Table 47. Eli Lilly Bipolar Disorder Product
    Table 48. Eli Lilly Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 49. Eli Lilly Recent Development
    Table 50. Allergan Plc. Company Details
    Table 51. Allergan Plc. Business Overview
    Table 52. Allergan Plc. Bipolar Disorder Product
    Table 53. Allergan Plc. Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 54. Allergan Plc. Recent Development
    Table 55. Novartis AG Company Details
    Table 56. Novartis AG Business Overview
    Table 57. Novartis AG Bipolar Disorder Product
    Table 58. Novartis AG Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 59. Novartis AG Recent Development
    Table 60. AbbVie Inc. Company Details
    Table 61. AbbVie Inc. Business Overview
    Table 62. AbbVie Inc. Bipolar Disorder Product
    Table 63. AbbVie Inc. Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 64. AbbVie Inc. Recent Development
    Table 65. Otsuka Holdings Ltd Company Details
    Table 66. Otsuka Holdings Ltd Business Overview
    Table 67. Otsuka Holdings Ltd Bipolar Disorder Product
    Table 68. Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 69. Otsuka Holdings Ltd Recent Development
    Table 70. AstraZeneca Company Details
    Table 71. AstraZeneca Business Overview
    Table 72. AstraZeneca Bipolar Disorder Product
    Table 73. AstraZeneca Revenue in Bipolar Disorder Business (2017-2022) & (US$ Million)
    Table 74. AstraZeneca Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bipolar Disorder Product Picture
    Figure 2. Global Bipolar Disorder Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Bipolar Disorder Market Size 2017-2028 (US$ Million)
    Figure 4. United States Bipolar Disorder Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Bipolar Disorder Market Size 2017-2028 (US$ Million)
    Figure 6. United States Bipolar Disorder Market Share in Global 2017-2028
    Figure 7. Bipolar Disorder Report Years Considered
    Figure 8. Product Picture of Bipolar I Disorder
    Figure 9. Product Picture of Bipolar II Disorder
    Figure 10. Product Picture of Cyclothymic Disorder
    Figure 11. Global Bipolar Disorder Market Share by Type in 2022 & 2028
    Figure 12. Global Bipolar Disorder Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Bipolar Disorder Market Share by Type (2017-2028)
    Figure 14. United States Bipolar Disorder Market Share by Type in 2022 & 2028
    Figure 15. United States Bipolar Disorder Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Bipolar Disorder Market Share by Type (2017-2028)
    Figure 17. Product Picture of Mood Stabilizers
    Figure 18. Product Picture of Anticonvulsants
    Figure 19. Product Picture of Antipsychotic drugs
    Figure 20. Product Picture of Antidepressant drugs
    Figure 21. Product Picture of Antianxiety drugs
    Figure 22. Product Picture of Others
    Figure 23. Global Bipolar Disorder Market Share by Application in 2022 & 2028
    Figure 24. Global Bipolar Disorder Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Bipolar Disorder Market Share by Application (2017-2028)
    Figure 26. United States Bipolar Disorder Market Share by Application in 2022 & 2028
    Figure 27. United States Bipolar Disorder Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Bipolar Disorder Market Share by Application (2017-2028)
    Figure 29. North America Bipolar Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. United States Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Mexico Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Bipolar Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. UK Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Bipolar Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Vietnam Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Bipolar Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Brazil Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Bipolar Disorder Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Bipolar Disorder Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Glaxo SmithKline (GSK) Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 57. Pfizer Inc. Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 58. Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 59. Eli Lilly Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 60. Allergan Plc. Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 61. Novartis AG Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 62. AbbVie Inc. Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 63. Otsuka Holdings Ltd Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 64. AstraZeneca Revenue Growth Rate in Bipolar Disorder Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Glaxo SmithKline (GSK)
Pfizer Inc.
Janssen Pharmaceuticals
Eli Lilly
Allergan Plc.
Novartis AG
AbbVie Inc.
Otsuka Holdings Ltd
AstraZeneca
Frequently Asked Questions
Bipolar Disorder report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Bipolar Disorder report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Bipolar Disorder report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports